Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma
about
Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression.Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps.Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet).Prognostic impact of lymphocytes in soft tissue sarcomasFrom 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer.An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma.Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells.Immunotherapy for head and neck cancer: advances and deficiencies.Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityInfiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.A new paradigm for an old story: the role of regulatory B cells in cancerPrognostic Value of Homotypic Cell Internalization by Nonprofessional Phagocytic Cancer Cells.Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signalsLow cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.Tumor-infiltrating B cells come into vogueAltered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccinesMolecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patientsHead and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients.Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.Immune cell infiltration patterns and survival in head and neck squamous cell carcinomaVariation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.The clinical implications of antitumor immunity in head and neck cancer.The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities.Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers.Adoptive T-cell therapy: a need for standard immune monitoring.Multiparametric immune profiling in HPV- oral squamous cell cancerPro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models.TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.IL-35 expression is increased in laryngeal squamous cell carcinoma and in the peripheral blood of patients.
P2860
Q26765429-5B8B634F-3187-4A27-84B9-A7985B2EACA4Q33615788-6C4752D0-37F2-4246-93A4-7CD359D18674Q33736438-91D241B6-924B-499D-8A21-EFC73DCD6252Q33783887-034535DF-5E9B-46DD-B1DA-810673FE4D0AQ33813250-A8489D9A-4C7B-4D1E-AE24-FC61B9F6E9BAQ33875700-7190A556-6D4E-40CC-9258-15236B7148C8Q34556117-87DF9621-BD73-4E19-8437-EF6CC5D0BB10Q34718331-398762DE-4EB7-40E1-B99C-3FA1605A0D55Q34972625-224E7E6F-6DDC-4705-92DD-47E995C43CC7Q35065243-D4C9AC6A-C7F9-434A-89C2-E91A0C11541FQ35072040-7F8964B7-6512-427D-8677-BF2BDDBD7ADEQ35588434-DCD167D2-32FF-4362-B006-BEC74FF48992Q35913813-3547BF13-7AE2-4B77-B4A0-988C93ABCA35Q36107944-34E1D389-F22E-430D-815D-21E66ABDCB9AQ36172869-A1356475-4D7F-49CF-A6C9-4A6E28E4EC29Q36413361-F33A8894-1419-49F2-B964-8B0868651888Q36511735-99B910D2-BA2E-4118-A6FA-48878B2092A4Q36525540-9717AD7F-001D-4911-8B4C-0C432C1CC9DCQ36721762-CD0820F7-008E-435F-87F6-2C73DCF5D683Q36745357-35E2DAD6-CFFF-467D-AE33-98E08D30BCC4Q37137360-DD24D48C-97A0-4461-8C7E-FD0481E38547Q37148418-4973BFD8-1DFD-44CC-9E31-9171530F8601Q37281368-14A4E9E3-F396-46B8-98C1-C74F69E69527Q37402113-66141666-829A-4A72-9501-0080B3D2F103Q37507341-A198EB18-AA0B-4F6A-900C-9288EA2ABBD0Q37509713-A8CFBCD1-CA5E-434E-B638-0FB900104FC7Q37559965-6CF2EBE8-F5A1-431A-B5B0-839FEA250EA7Q37692604-38D49EB9-1A8F-457E-85CF-00CDD6B6EB68Q37945304-A7FDAC00-EC8F-4E6F-AC3C-150C11E6314AQ37970005-6D3C778E-6B9C-4753-8B8C-835298995C48Q38079588-2EDC404F-DDD4-4460-A9C5-96A980AD5A5EQ38161874-2B2E348A-0C38-467C-BDEF-2DBC9A77B700Q38201655-E8E6969C-3B49-4D8F-8574-12C54705E2A8Q38209889-6608A586-E720-4015-AE11-2E9668188B76Q38525029-DED53B60-1645-4AB7-9A4A-BC1858D88892Q38671420-966AD171-E099-4995-8C4D-D5ABCA3C98C0Q38843707-4A7CC648-F441-4150-9458-400FF1A922FDQ39055075-4705DC85-756D-46F1-80FE-729F7743EED6Q39376252-55F9B0C0-CD91-435B-91E0-BE8DCB62C13FQ40196332-DCDEF964-2417-4EAB-8177-5ACB71E0FE38
P2860
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@ast
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@en
type
label
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@ast
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@en
prefLabel
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@ast
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@en
P2093
P2860
P356
P1433
P1476
Distribution of immune cells i ...... - and hypopharyngeal carcinoma
@en
P2093
Dominik Pretscher
Gerhard G Grabenbauer
Maike Buettner
Michael Wittlinger
P2860
P2888
P356
10.1186/1471-2407-9-292
P407
P577
2009-08-22T00:00:00Z
P5875
P6179
1021436596